Spironolactone does not reduce risk for cardiovascular morbidity, mortality in patients on dialysis
Spironolactone does not reduce a composite outcome of cardiovascular mortality and hospitalization due to heart failure among patients receiving maintenance dialysis, according to a study published online Aug. 16 in The Lancet ...
Aug 28, 2025
0
8









